Table 1 Patient demographics and baseline characteristics
n = 179 | |
|---|---|
Age, mean (SD), y | 37.3 (13.3) |
Male, n (%) | 130 (72.6) |
Body mass index, mean (SD), kg/m2 | 18.8 (3.06) |
Physical status, n (%) | |
ASA 1 | 3 (1.7) |
ASA 2 | 167 (93.3) |
ASA 3 | 9 (5.0) |
Comorbidities, n (%) | |
Coagulopathy | 149 (83.2) |
Anemia | 146 (81.6) |
Hypoalbuminemia | 120 (67.0) |
Bronchial asthma | 7 (3.9) |
Diabetes mellitus | 6 (3.4) |
Hypertension | 6 (3.4) |
Ischemic heart disease | 5 (2.8) |
Cerebrovascular disease | 2 (1.1) |
Current smoking, n (%) | 23 (12.8) |
Nerve blocks, n (%) | |
Preoperative TAP block | 88 (49.2) |
Preoperative QLB | 48 (26.8) |
Preoperative TAP & QLB | 2 (1.1) |
Operative time, mean (SD), min | 243.8 (87.2) |
Intraoperative fentanyl consumption, mean (SD), mcg | 12.6 (4.2) |
Postoperative fentanyl consumption, mean (SD), mcg/kg/day | 30.7 (14.1) |